Ocular hypertension

Revision as of 14:28, 20 August 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Ocular hypertension
ICD-10 H40.0
ICD-9 365.04
DiseasesDB 5226
eMedicine oph/578 
MeSH D009798


Ocular hypertension (OHT) is intraocular pressure higher than normal in the absence of optic nerve damage or visual field loss.[1][2]

Current consensus in ophthalmology defines normal introcular pressure (IOP) as that between 10 mmHg and 21 mmHg.[3][4] Elevated IOP is the most important risk factor for glaucoma, so those with ocular hypertension are frequently considered to have a greater chance of developing the condition.

Intraocular pressure can increase when a patient lies down. There is evidence that some glaucoma patients (e.g., normal tension glaucoma patients) with normal IOP while sitting or standing may have intraocular pressure that is elevated enough to cause problems when they are lying down.

Treatment

Medication

Ocular hypertension are mostly treated with pilocarpine, timolol, acetazolamide and clonidine[5]. There are also other, less commonly used, alternatives. Eye drops may initially be started either in one or in both eyes.[6]

Comparison table of ocular antihypertensives
Medication Mechanism Dosage form[7] Adverse effects[7]
pilocarpine muscarinic agonist eye drops
timolol β-receptor antagonist
acetazolamide carbonic anhydrase inhibitor systemic administration
clonidine α2-receptor agonist eye drops
ecothiopate cholinesterase inhibitor eye drops
carteolol β-receptor antagonist eye drops
dorzolamide carbonic anhydrase inhibitor eye drops
  • bitter taste
  • burning sensation
apraclonidine α-2 agonist eye drops
latanoprost prostaglandin analogue

References

  1. American Academy of Ophthalmology
  2. American Optometric Association
  3. webMD
  4. eMedicine - Glaucoma Overview
  5. Rang, H. P. (2003). Pharmacology. Edinburgh: Churchill Livingstone. ISBN 0-443-07145-4. Page 146
  6. [ http://www.biomedcentral.com/1471-2415/7/17 Interpretation of uniocular and binocular trials of glaucoma medications]
  7. 7.0 7.1 Unless else specified in boxes, then ref is: Rang, H. P. (2003). Pharmacology. Edinburgh: Churchill Livingstone. ISBN 0-443-07145-4. Page 146

External links

Template:WikiDoc Sources